Lv11
20 积分 2023-10-16 加入
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets
5小时前
已完结
Leveraging artificial intelligence for neoantigen prediction
29天前
已完结
Honing CAR T cells to tackle acute myeloid leukemia
1个月前
已完结
Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy
1个月前
已完结
Overweight, inflammation of normal colorectal mucosa, and cancer risk
2个月前
已完结
Knowledge-enhanced AI to Supercharge ADC Development for Treatment of Cancer
2个月前
已关闭
Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody–drug conjugates
4个月前
已完结
Advances in artificial intelligence for drug delivery and development: A comprehensive review
4个月前
已完结
Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?
5个月前
已完结
Microenvironment mapping via Dexter energy transfer on immune cells
5个月前
已完结
Diffusion-based Time Series Imputation and Forecasting with Structured State Space Models
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGC936 (Anti-ADAM9 Antibody Drug Conjugate) in Patients With Advanced Solid Tumors
皖公网安备34019202002308
